Back to top
more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

96.59
692,880

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tandem Diabetes (TNDM) Q2 Earnings & Revenues Top Estimates

by Zacks Equity Research

Tandem Diabetes' (TNDM) strong domestic pump sales and pump shipments boosted the top line.

Integer Holdings (ITGR) Q2 Earnings Miss Estimates, Down Y/Y

by Zacks Equity Research

Integer Holdings' (ITGR) second-quarter results reflect from weak segmental performance and margin contraction.

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Stryker's (SYK) second-quarter earnings reflect weak segmental performance.

OPKO Health (OPK) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

OPKO Health's (OPK) second-quarter results benefit from increase in RAYALDEE prescriptions.

Can PerkinElmer (PKI) Run Higher on Rising Earnings Estimates?

by Zacks Equity Research

PerkinElmer (PKI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CONMED (CNMD) Q2 Loss Narrower Than Expected, Revenues Top

by Zacks Equity Research

CONMED's (CNMD) core units - General Surgery and Orthopedic Surgery - witnessed revenue decline in Q2.

Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Merit Medical (MMSI) reported a drop in revenues at every key operating segment in Q2.

Baxter (BAX) Earnings and Revenues Miss Estimates in Q2

by Zacks Equity Research

Baxter's (BAX) second-quarter earnings reflect weak performance across Medication Delivery, Pharmaceutical and Advanced Surgery business units and contraction in margins.

Cerner (CERN) Q2 Earnings Surpass Estimates, Revenues Miss

by Zacks Equity Research

Cerner (CERN) second-quarter results benefit from gains in Subscriptions and Managed services units, and expansion in margins.

The Zacks Analyst Blog Highlights: FTV, PKI, GNRC, CARR and MTD

by Zacks Equity Research

The Zacks Analyst Blog Highlights: FTV, PKI, GNRC, CARR and MTD

PerkinElmer (PKI) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

PerkinElmer's (PKI) second-quarter results benefit from growth in Diagnostics segment. However, forex remains a woe.

PerkinElmer (PKI) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

PerkinElmer (PKI) delivered earnings and revenue surprises of 68.82% and 1.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

KLA-Tencor (KLAC) to Post Q4 Earnings: What's in the Cards?

by Zacks Equity Research

KLA-Tencor's (KLAC) fiscal fourth-quarter results are likely to reflect strong demand in Process Control systems and solid execution.

Nalak Das headshot

Buy 5 Technology Stocks Set to Beat on Q2 Earnings This Week

by Nalak Das

Several important companies from technology sector will report results this week. A few of them, with a favorable Zacks Rank, are set to beat earnings estimates.

Mettler-Toledo (MTD) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Mettler-Toledo International's (MTD) second-quarter results are likely to reflect strength across Laboratory and Industrial segments amid the coronavirus pandemic.

    Carrier Global (CARR) to Report Q2 Earnings: What's in Store?

    by Zacks Equity Research

    Carrier Global's (CARR) Q2 performance is expected to have gained from a fast-recovering China economy and seasonal strength in HVAC business despite the adverse impact of the coronavirus pandemic.

    Is a Surprise Coming for PerkinElmer (PKI) This Earnings Season?

    by Zacks Equity Research

    PerkinElmer (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

    MSCI Gearing Up to Report Q2 Earnings: What's in the Cards?

    by Zacks Equity Research

    MSCI's Q2 earnings are expected to have gained from robust adoption of its solutions despite the adverse impact of the coronavirus pandemic.

    PerkinElmer (PKI) to Post Q2 Earnings: What's in the Cards?

    by Zacks Equity Research

    PerkinElmer's (PKI) second-quarter results are likely to reflect strong performance at Diagnostics segment. However, forex remained a woe.

    PerkinElmer (PKI) Launches DBS Test for Coronavirus Diagnosis

    by Zacks Equity Research

    PerkinElmer (PKI) unveils DBS-based test, being marketed as a CE-IVD test, while intending to apply for its FDA EUA soon.

    Can PerkinElmer (PKI) Keep the Earnings Surprise Streak Alive?

    by Zacks Equity Research

    PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    PerkinElmer (PKI) Is Up 3.6% in One Week: What You Should Know

    by Zacks Equity Research

    Does PerkinElmer (PKI) have what it takes to be a top stock pick for momentum investors? Let's find out.

    Zacks.com featured highlights include: Owens Corning, Macquarie Infrastructure, PerkinElmer, Portland General Electric and TransUnion

    by Zacks Equity Research

    Zacks.com featured highlights include: Owens Corning, Macquarie Infrastructure, PerkinElmer, Portland General Electric and TransUnion

    Badger Meter (BMI) Q2 Earnings & Revenues Miss Estimates

    by Zacks Equity Research

    Thanks to COVID-19 related uncertainties, Badger Meter's (BMI) second-quarter 2020 earnings and revenues decline year over year with lower demand across various end-markets.

    Swayta Shah headshot

    5 Stocks With Robust Sales Growth Worth Betting on Right Now

    by Swayta Shah

    Sales growth is one of the most reliable metrics for picking profitable stocks amid a challenging operating backdrop.